Search results for "Dependence"

showing 10 items of 2462 documents

Influence of the Novelty-Seeking Endophenotype on the Rewarding Effects of Psychostimulant Drugs in Animal Models

2015

Novelty seeking (NS), defined as a tendency to pursue novel and intense emotional sensations and experiences, is one of the most relevant individual factors predicting drug use among humans. High novelty seeking (HNS) individuals present an increased risk of drug use compared to low novelty seekers. The NS endophenotype may explain some of the differences observed among individuals exposed to drugs of abuse in adolescence. However, there is little research about the particular response of adolescents to drugs of abuse in function of this endophenotype, and the data that do exist are inconclusive. The present work reviews the literature regarding the influence of NS on psychostimulant reward…

DrugEndophenotypesself-administration.media_common.quotation_subjectnovelty seekingVulnerabilityArticleDevelopmental psychologypsychostimulants03 medical and health sciences0302 clinical medicineRewardmedicineAnimalsHumansPharmacology (medical)media_commonPharmacologySubstance dependenceNovelty seekingNoveltyGeneral Medicinerewarding effectsmedicine.diseaseconditioned place preferenceConditioned place preferenceAnimal models030227 psychiatryBehavior AddictivePsychiatry and Mental healthNeurologyEndophenotypeModels AnimalExploratory BehaviorTraitCentral Nervous System StimulantsNeurology (clinical)Psychology030217 neurology & neurosurgeryCurrent Neuropharmacology
researchProduct

Preclinical evidence of new opioid modulators for the treatment of addiction.

2010

Addiction to opiates is one of the most severe forms of substance dependence, and despite a variety of pharmacological approaches to treat it, relapse is observed in a high percentage of subjects. New pharmacological compounds are necessary to improve the outcome of treatments and reduce adverse side effects. Moreover, drugs that act on the opioid system can also be of benefit in the treatment of alcohol or cocaine addiction. AREA COVERED BY THIS REVIEW: Recent preclinical studies of pharmacological agents for the treatment of opiate addiction (2008 to the present date).The reader will be informed of the latest drugs shown in animal models to modify dependence on opiates and the reinforcing…

DrugGABA Agentsmedia_common.quotation_subjectNarcotic AntagonistsDrug Evaluation PreclinicalReceptors Opioid muPharmacologyReceptors NicotinicBioinformaticsPharmacotherapyDopamineReceptors Opioid deltaCannabinoid Receptor ModulatorsmedicineAdrenergic alpha-2 Receptor AgonistsAnimalsPharmacology (medical)Adverse effectmedia_commonPharmacologySubstance dependencebusiness.industryAddictionReceptors Opioid kappaAntagonistGeneral Medicinemedicine.diseaseOpioid-Related DisordersRatsSubstance Withdrawal SyndromeOpioidReceptors OpioidDopamine AntagonistsFemalebusinessExcitatory Amino Acid Antagonistsmedicine.drugExpert opinion on investigational drugs
researchProduct

Pharmacology of Acamprosate: An Overview

2003

In the last years important advances have been made in the development of drugs for the treatment of alcohol addiction. Acamprosate (calcium bis‐acetylhomotaurine) is one of the better established drugs in this field on the European market. This review focuses first on the pharmacokinetics of acamprosate. The published data and the recent advances in our knowledge on the mechanisms involved in the intestinal absorption and elimination of this drug are summarized. The importance of pharmacokinetics for the proper clinical use of acamprosate is highlighted. The anti‐relapse as well as the well‐known effects of acamprosate on ethanol intake are discussed. The recent experiments in animal model…

DrugTaurineAcamprosatemedia_common.quotation_subjectBiological AvailabilityPharmacologyReceptors N-Methyl-D-AspartateArticleIntestinal absorptionmedicineAnimalsHumansEuropean marketmedia_commonPharmacologyAlcohol addictionAlcohol dependenceAlcoholismNeuropsychology and Physiological PsychologyAcamprosateIntestinal AbsorptionEthanol intakePsychologyAlcohol Deterrentsmedicine.drugBiological availability
researchProduct

The control of abstinence in the treatment of alcohol dependence: the use of acamprosate in relapse prevention

2014

"The alcoholism can also deal with drug treatments." This is the message that emerges from the press conference of presentation of Campral, trade name of acamprosate, a neuromodulator specifically indicated in the maintenance of abstinence in alcohol-dependent patients.Alcoholism is a disease characterized by: craving, loss of control, tolerance and physical dependence.For many years the prevention of relapse in use of alcohol after detoxification was supported almost exclusively by psychosocial procedures and techniques with modest success. Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addiction, abuse or withdrawal of its suspension and does n…

Drugmedicine.medical_specialtymedia_common.quotation_subjectCravingPlant ScienceRelapse preventionSettore BIO/09 - FisiologiaGeneral Biochemistry Genetics and Molecular BiologymedicineSocial determinants of healthPsychiatrylcsh:QH301-705.5media_commonbusiness.industryAddictionBiochemistry (medical)Alcohol dependenceAbstinenceSettore CHIM/08 - Chimica FarmaceuticaAcamprosatelcsh:Biology (General)Settore BIO/14 - Farmacologiaalcoholism acamprosate relapseabstinence acamprosatemedicine.symptomAlcohol dependence Acamprosatebusinessmedicine.drugJournal of Biological Research
researchProduct

Inferring slowly-changing dynamic gene-regulatory networks

2015

Dynamic gene-regulatory networks are complex since the interaction patterns between their components mean that it is impossible to study parts of the network in separation. This holistic character of gene-regulatory networks poses a real challenge to any type of modelling. Graphical models are a class of models that connect the network with a conditional independence relationships between random variables. By interpreting these random variables as gene activities and the conditional independence relationships as functional non-relatedness, graphical models have been used to describe gene-regulatory networks. Whereas the literature has been focused on static networks, most time-course experi…

Dynamic network analysisL1 penalized inferenceComputer scienceT-LymphocytesGene regulatory networkgene regulatory networkMachine learningcomputer.software_genreBiochemistrygene-regulatory networksStructural Biologygraphical modelscomputer simulationT lymphocyteHumansGene Regulatory NetworkshumanGraphical modelMolecular Biologylymphocyte activationClass (computer programming)Models Statisticalalgorithmbusiness.industryResearchApplied Mathematicsstatistical modelStatistical modelComplex networkQuantitative Biology::GenomicsComputer Science ApplicationsComputingMethodologies_PATTERNRECOGNITIONConditional independencemicroarray analysisComputingMethodologies_GENERALArtificial intelligencebusinessmetabolismRandom variablecomputerAlgorithmsBMC Bioinformatics
researchProduct

"Table 1" of "Inclusive cross sections, charge ratio and double-helicity asymmetries for $\pi^+$ and $\pi^-$ production in $p$$+$$p$ collisions at $\…

2016

Invariant cross section for $\pi^+$ and $\pi^-$ hadrons, as well as the statistical and systematic uncertainties. In addition, there is an absolute scale uncertainty of 9.6$\%$.

E*D3SIG/DP**3InclusiveSingle Differential Cross SectionProton-Proton ScatteringHigh Energy Physics::ExperimentDSIG/DPTP P --> PI+ XP P --> PI- XTransverse Momentum DependenceInvariant Cross Section200.0
researchProduct

"Table 1" of "Exclusive production of pion and kaon meson pairs in two photon collisions at LEP."

2003

Measured angular distribution for pion production.

E+ E- --> E+ E- PI+ PI-Electron productionHigh Energy Physics::LatticeNuclear TheoryGAMMA GAMMA --> PI+ PI-0.0Single Differential Cross SectionPhotoproductionE+ E- ScatteringDSIG/DCOSTHETATwo-PhotonExclusiveHigh Energy Physics::ExperimentNuclear ExperimentAngular Dependence
researchProduct

"Table 39" of "Properties of hadronic Z decays and test of QCD generators"

1992

Transverse momentum, PTOUT, distribution.

E+ E- --> HADRONSE+ E- --> Z0E+ E- ScatteringExclusive91.2Single Differential DistributionDN/DPTOUTNuclear ExperimentTransverse Momentum Dependence
researchProduct

"Table 38" of "Properties of hadronic Z decays and test of QCD generators"

1992

Transverse momentum, PTOUT, distribution.

E+ E- --> HADRONSE+ E- --> Z0E+ E- ScatteringExclusive91.2Single Differential DistributionDN/DPTOUTNuclear ExperimentTransverse Momentum Dependence
researchProduct

"Table 40" of "Properties of hadronic Z decays and test of QCD generators"

1992

Transverse momentum, PTIN, distribution.

E+ E- --> HADRONSE+ E- --> Z0E+ E- ScatteringExclusive91.2Single Differential DistributionNuclear ExperimentTransverse Momentum DependenceDN/DPTIN
researchProduct